1-环丙基-2-硝基苯 | 10292-65-6

• 分子结构分类: 有机化合物 - 苯类化合物 - 苯和取代衍生物
• 中文名称: 1-环丙基-2-硝基苯
• 英文名称: 2-nitrophenylcyclopropane
• 英文别名: 1-cyclopropyl-2-nitrobenzene
• CAS: 10292-65-6
• 化学式: C₉H₉NO₂
• mdl: MFCD00102065
• 分子量: 163.176
• InChiKey: VANZICVFDGMCIU-UHFFFAOYSA-N

物化性质

• 沸点：
  106 °C(Press: 6 Torr)
• 密度：
  1.167 g/cm3

计算性质

• 辛醇/水分配系数(LogP)：
  2.8
• 重原子数：
  12
• 可旋转键数：
  1
• 环数：
  2.0
• sp3杂化的碳原子比例：
  0.333
• 拓扑面积：
  45.8
• 氢给体数：
  0
• 氢受体数：
  2

反应信息

• 作为反应物：
  描述：

  1-环丙基-2-硝基苯 在 palladium on activated charcoal 氢气 、 potassium carbonate 、 sodium iodide 作用下， 以 乙醇 、 二乙二醇二甲醚 为溶剂， 反应 19.5h， 生成 1-(2-cyclopropylphenyl)piperazine
  参考文献：
  名称：

  N-Arylpiperazinyl-N‘-propylamino Derivatives of Heteroaryl Amides as Functional Uroselective α₁-Adrenoceptor Antagonists

  摘要：

  Novel arylpiperazines were identified as alpha(1)-adrenoceptor(BR) subtype-selective antagonists by functional in vitro screening. 3-[4-(ortho-Substituted phenyl)piperazin-1-yl]propylamines were derivatized with N,N-dimethyl anthranilamides, nicotinamides,;as well as carboxamides of quinoline, I,8-naphthyridine, pyrazolo[3,4-b]pyridine, isoxazolo[3,4-b]pyridine, imidazo[4,5-b]pyridine, and pyrazolo[1,5-a]pyrimidines. Strips of rabbit bladder neck were employed as a predictive assay for antagonism in the human lower tract. Rings of rat aorta;a were used as a ''negative screen'' for the test antagonists. Binding to alpha(1)-ARs was relatively sensitive to size and electronic features of the arylpiperazine portion of the antagonists and permissive to these features on the heteroaryl carboxamide side. These structure-affinity findings were exploited to produce nicotinamides (e.g, 13ii and 25x) and pyrazolo[3,4-b]pyridines (e.g. 37f and 37y) ligands with nanomolar affinity at the alpha(1)-AR subtype prevalent in the human lower urinary tract (pA(2) values: 8.8, 10.7, 9.3, and 9.9, respectively) and displaying 2-3 orders of magnitude selectivity over the alpha(1D)-AR.

  DOI：

  10.1021/jm970166j
• 作为产物：
  描述：

  环丙基苯 在 硝酸 、 乙酸酐 作用下， 生成 1-环丙基-2-硝基苯
  参考文献：
  名称：

  Lewina et al., Zhurnal Obshchei Khimii, 1959, vol. 29, p. 3233,3235; engl. Ausg. S. 3196, 3198

  摘要：

  DOI：

文献信息

• Synthesis of <i>meta</i>-Substituted Anilines via Copper-Catalyzed [1,3]-Methoxy Rearrangement
  作者：Itaru Nakamura、Hiroki Tashiro、Yasuhiro Ishida、Masahiro Terada

  DOI：10.1021/acs.orglett.0c01009

  日期：2020.5.15

  copper-catalyzed [1,3]-methoxy rearrangement of N-methoxyanilines followed by Michael addition of nucleophiles to the in situ generated ortho-quinol imine. The present reaction exhibits excellent applicability of para-substituents, such as vinyl, methylthio, ester, and bromo, and carbon nucleophiles, such as 1,3,5-trimethoxybenzene, N-methylindole, and dimethyl malonate. Thus, the present rearrangement can resolve

  通过铜催化的N-甲氧基苯胺的[1,3]-甲氧基重排，然后将亲核试剂迈克尔加成到原位生成的邻苯二酚亚胺，可以高效地合成间位取代的苯胺。本反应显示出对位取代基如乙烯基，甲硫基，酯和溴的良好适用性，以及碳亲核试剂如1,3,5-三甲氧基苯，N-甲基吲哚和丙二酸二甲酯的优异适用性。因此，本发明的重排可以解决由氧化反应引起的问题，例如使用化学计量的氧化剂和吸电子基团的低相容性。
• [EN] SUBSTITUTED TRICYCLIC COMPOUNDS WITH ACTIVITY TOWARDS EP1 RECEPTORS<br/>[FR] COMPOSÉS TRICYCLIQUES SUBSTITUÉS POSSÉDANT UNE ACTIVITÉ CONTRE LES RÉCEPTEURS EP1
  申请人：ALMIRALL SA

  公开号：WO2013149997A1

  公开（公告）日：2013-10-10

  The present invention belongs to the field of EP1 receptor ligands. More specifically it refers to compounds of general formula (I) having great affinity and selectivity for the EP1 receptor. The invention also refers to the process for their preparation, to their use as medicament for the treatment and/or prophylaxis of diseases or disorders mediated by the EP1 receptor as well as to pharmaceutical compositions comprising them.

  本发明属于EP1受体配体领域。更具体地，它涉及具有对EP1受体具有很高亲和力和选择性的一般式(I)化合物。该发明还涉及它们的制备方法，以及它们作为药物用于治疗和/或预防由EP1受体介导的疾病或紊乱，以及包含它们的药物组合物。
• N-acylaminophenylcyclopropanes in reaction with nitrous acid generated in situ
  作者：S. S. Mochalov、R. A. Gazzaeva、A. Z. Kadzhaeva、A. N. Fedotov、E. V. Trofimova

  DOI：10.1007/s10593-012-0929-y

  日期：2012.2

  regioselectively with introduction of an N = O fragment into the three-membered ring and formation of the corresponding Δ2-isoxazolines. For ortho-substituted N-acylaminophenylcyclopropanes side processes were observed, caused by the intramolecular participation of the N-acyl group in conversions of the carbenium ions formed on opening the cyclopropane ring under the action of the nitrosating reagent

  的反应Ñ与HNO -acylaminophenylcyclopropanes 2点进行区域选择性地与引入N-的= O片段到三元环和形成相应Δ的2 -isoxazolines。为邻位取代的Ñ观察-acylaminophenylcyclopropanes端进程，由所述的分子内参与引起Ñ酰基团在形成于所述亚硝化试剂的作用下打开环丙烷环的碳正离子的转化，以及由修改的直接插入邻取代基成三元环。
• Method for Producing Alkenylnitrobenzene Derivatives Unbranched in the 1'-Position
  申请人：Straub Alexander

  公开号：US20100076229A1

  公开（公告）日：2010-03-25

  The present invention relates to a process for preparing alkenylnitrobenzenes and alkylanilines, which are of significance as intermediates for fungicidally active alkylanilides.

  本发明涉及一种制备烯烃基硝基苯和烷基苯胺的方法，这些化合物作为杀真菌活性的烷基苯酰胺的中间体具有重要意义。
• PYRAZOLE DERIVATIVES AS ANTI-PLATELET AND ANTI-THROMBOTIC AGENTS
  申请人：Chi Liguo

  公开号：US20080269293A1

  公开（公告）日：2008-10-30

  This invention relates to novel compounds of formula (I) or stereoisomers or pharmaceutically acceptable salts thereof wherein Y, R 1 through R 9 , and X 1 through X 7 are as defined in the specification, pharmaceutical compositions containing said compounds useful as P2Y 1 antagonists, and to methods of treating thromboembolic disorders.

  本发明涉及公式（I）的新化合物或其立体异构体或药学上可接受的盐，其中Y，R1至R9和X1至X7如规范中定义的，包含该化合物的制药组合物作为P2Y1拮抗剂有用，并用于治疗血栓栓塞性疾病的方法。

表征谱图